Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Philip Poorvu's Talks
Philip Poorvu
Dana-Farber Cancer Institute
DAISY: Early clues to T-DXd resistance
October 20, 2026
Philip Poorvu
Dana-Farber Cancer Institute
00:00
--:--
The DAISY trial evaluated how much HER2 is needed for T-DXd
October 20, 2026
Share
The DAISY trial evaluated how much HER2 is needed for T-DXd
https://www.medspoke.co/channel_playlist?object_id=879&tap_id=15974
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Philip Poorvu
Dana-Farber Cancer Institute
Why HER2 low became targetable
October 20, 2026
Why are you reporting this TALK?
